Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.

Hibi T, Rela M, Eason J, Line PD, Fung J, Sakamoto S, Selzner N, Man NK, Ghobrial RM, Sapisochin G.

Transplantation. 2020 Mar 23. doi: 10.1097/TP.0000000000003118. [Epub ahead of print]

PMID:
32217939
2.

Renal dysfunction after liver transplantation: effect of donor type.

Kollmann D, Neong SF, Rosales R, Hansen BE, Sapisochin G, McCluskey S, Bhat M, Cattral MS, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M, Wong FSH, Selzner N.

Liver Transpl. 2020 Mar 19. doi: 10.1002/lt.25755. [Epub ahead of print]

PMID:
32189415
3.

Normothermic Ex Vivo Liver Perfusion Prevents Intrahepatic Platelet Sequestration After Liver Transplantation.

Kollmann D, Linares-Cervantes I, Ganesh S, Rosales R, Hamar M, Goto T, Urbanellis P, Tessandier N, Boilard E, Bruguera C, Wiebe A, Bartczak A, Yip P, Adeyi O, Selzner M, Selzner N.

Transplantation. 2020 Feb 21. doi: 10.1097/TP.0000000000003194. [Epub ahead of print]

PMID:
32091485
4.

The Impact of Direct Acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.: An International Multicenter Study.

Gorgen A, Galvin Z, Huang AC, Vinaixa C, O'Rourke JM, Francoz C, Hansen BE, Durand F, Elsharkawy AM, Shah T, Berenguer M, Rubin A, Calatayud D, Mehta N, Terrault NA, Lilly LB, Selzner N, Sapisochin G.

Transplantation. 2020 Jan 16. doi: 10.1097/TP.0000000000003115. [Epub ahead of print]

PMID:
31978002
5.

Clinical predictors of progression and clearance of low-level CMV DNAemia in solid organ transplant recipients.

Natori Y, Alghamdi A, Husain S, Rotstein C, Selzner N, Tikkanen J, Schiff J, Humar A, Kumar D.

Transpl Infect Dis. 2020 Feb;22(1):e13207. doi: 10.1111/tid.13207. Epub 2019 Nov 19.

PMID:
31677321
6.

Cell-Mediated Immune Responses After Influenza Vaccination of Solid Organ Transplant Recipients: Secondary Outcomes Analyses of a Randomized Controlled Trial.

L'huillier AG, Ferreira VH, Hirzel C, Natori Y, Slomovic J, Ku T, Hoschler K, Ierullo M, Selzner N, Schiff J, Singer LG, Humar A, Kumar D.

J Infect Dis. 2020 Jan 1;221(1):53-62. doi: 10.1093/infdis/jiz471.

PMID:
31550354
7.

Cytomegalovirus: The "Troll of Transplantation" Is Now the "Troll of Tolerance".

Kumar D, Selzner N.

Transplantation. 2020 Feb;104(2):238-239. doi: 10.1097/TP.0000000000002894. No abstract available.

PMID:
31356575
8.

Donor outcomes in anonymous live liver donation.

Goldaracena N, Jung J, Aravinthan AD, Abbey SE, Krause S, Pritlove C, Lynch J, Wright L, Selzner N, Stunguris J, Greig P, Ghanekar A, McGilvray I, Sapisochin G, Ng VL, Levy G, Cattral M, Grant D.

J Hepatol. 2019 Nov;71(5):951-959. doi: 10.1016/j.jhep.2019.06.027. Epub 2019 Jul 4.

PMID:
31279899
9.

Liver Transplantation for Acute Liver Failure Due to Dengue Fever.

Galante A, Adeyi O, Lau L, Humar A, Galvin Z, Selzner N, Lilly L, Sapisochin G, Bhat M.

Hepatology. 2019 Nov;70(5):1863-1865. doi: 10.1002/hep.30803. Epub 2019 Aug 9. No abstract available.

PMID:
31162847
10.

Predictor parameters of liver viability during porcine normothermic ex situ liver perfusion in a model of liver transplantation with marginal grafts.

Linares-Cervantes I, Echeverri J, Cleland S, Kaths JM, Rosales R, Goto T, Kollmann D, Hamar M, Urbanellis P, Mazilescu L, Ganesh S, Adeyi OA, Yip P, Goryńska P, Bojko B, Goryński K, Grant DR, Selzner N, Wąsowicz M, Selzner M.

Am J Transplant. 2019 Nov;19(11):2991-3005. doi: 10.1111/ajt.15395. Epub 2019 May 28.

PMID:
31012532
11.

Impact of Different Clinical Perfusates During Normothermic Ex Situ Liver Perfusion on Pig Liver Transplant Outcomes in a DCD Model.

Linares-Cervantes I, Kollmann D, Goto T, Echeverri J, Kaths JM, Hamar M, Urbanellis P, Mazilescu L, Rosales R, Bruguera C, Oquendo F, Ganesh S, Adeyi OA, Yip P, Selzner N, Selzner M.

Transplant Direct. 2019 Mar 4;5(4):e437. doi: 10.1097/TXD.0000000000000876. eCollection 2019 Apr.

12.

The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation.

Aravinthan AD, Fateen W, Doyle AC, Venkatachalapathy SV, Issachar A, Galvin Z, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Grant DR, Selzner N, Lilly LB, Renner EL, Bhat M.

Transplantation. 2019 Dec;103(12):2523-2530. doi: 10.1097/TP.0000000000002757.

PMID:
30985734
13.

Attitudes of Liver Transplant Candidates Toward Organs From Increased-Risk Donors.

Humar SS, Liu J, Pinzon N, Kumar D, Bhat M, Lilly L, Selzner N.

Liver Transpl. 2019 Jun;25(6):881-888. doi: 10.1002/lt.25467.

PMID:
30947392
14.

Obesity: Weighty Challenges for the Liver Transplant Community.

Selzner N, Grant D.

Liver Transpl. 2019 Apr;25(4):531-532. doi: 10.1002/lt.25437. No abstract available.

15.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Apr;70(4):666-673. doi: 10.1016/j.jhep.2018.12.029. Epub 2019 Jan 8.

PMID:
30630009
16.

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5.

PMID:
30615906
17.

Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.

Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M.

Liver Transpl. 2019 Jan;25(1):56-67. doi: 10.1002/lt.25338.

18.

Steatosis in Liver Transplantation: Current Limitations and Future Strategies.

Linares I, Hamar M, Selzner N, Selzner M.

Transplantation. 2019 Jan;103(1):78-90. doi: 10.1097/TP.0000000000002466. Review.

PMID:
30418431
19.

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations.

MacParland SA, Liu JC, Ma XZ, Innes BT, Bartczak AM, Gage BK, Manuel J, Khuu N, Echeverri J, Linares I, Gupta R, Cheng ML, Liu LY, Camat D, Chung SW, Seliga RK, Shao Z, Lee E, Ogawa S, Ogawa M, Wilson MD, Fish JE, Selzner M, Ghanekar A, Grant D, Greig P, Sapisochin G, Selzner N, Winegarden N, Adeyi O, Keller G, Bader GD, McGilvray ID.

Nat Commun. 2018 Oct 22;9(1):4383. doi: 10.1038/s41467-018-06318-7.

20.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

Supplemental Content

Loading ...
Support Center